4.7 Article

Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Prospects for Minocycline Neuroprotection

Jennifer M. Plane et al.

ARCHIVES OF NEUROLOGY (2010)

Article Clinical Neurology

Pilot study of minocycline in relapsing-remitting multiple sclerosis

Yunyan Zhang et al.

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2008)

Review Clinical Neurology

A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results

Karl Kieburtz et al.

CLINICAL NEUROPHARMACOLOGY (2008)

Article Biochemistry & Molecular Biology

Minocycline neuroprotects, reduces microgliosis, and inhibits caspase protease expression early after spinal cord injury

Barry W. Festoff et al.

JOURNAL OF NEUROCHEMISTRY (2006)

Article Multidisciplinary Sciences

Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury

YD Teng et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Review Clinical Neurology

The promise of minocycline in neurology

VW Yong et al.

LANCET NEUROLOGY (2004)

Article Clinical Neurology

Inhibition of autoimmune encephalomyelitis by a tetracycline

N Popovic et al.

ANNALS OF NEUROLOGY (2002)